Advertisement
Advertisement
AMRN
Amarin Corp Plc
13.72
USDSponsored
-0.03
-0.22%
Sep 23, 16:00 UTC -4
Closed
After-Market
13.71
-0.01
-0.07%
AMRN Earnings Reports
Positive Surprise Ratio
AMRN beat 28 of 43 last estimates.
65%
Next Report
Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$44.58M
/-$0.02
Implied change from Q2 26 (Revenue/ EPS)
+5.62%
/-150.00%
Implied change from Q3 25 (Revenue/ EPS)
-10.24%
/-125.00%
Amarin Corp Plc earnings per share and revenue
On Jul 29, 2026, AMRN reported earnings of 0.04 USD per share (EPS) for Q2 26, beating the estimate of -0.01 USD, resulting in a 492.16% surprise. Revenue reached 42.21 million, compared to an expected 45.44 million, with a -7.11% difference. The market reacted with a +1.51% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 44.58 million USD, implying an decrease of -150.00% EPS, and increase of 5.62% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AnaptysBio, Inc. Common Stock
Report Date
Sep 21, 2026 For Q2 26
Estimate
$0.00
Actual
$5.11
Surprise
>+10,000.00%
BlossomHill Therapeutics, Inc. Common Stock
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$1.03
Actual
-$8.75
Surprise
-746.56%
Vogenx Inc Common Stock
Report Date
Sep 17, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+1.96%
Benitec Biopharma Inc. Common Stock
Report Date
Sep 14, 2026 For Q4 26
Estimate
-$0.27
Actual
-$0.26
Surprise
+5.59%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Abivax SA - ADR
Report Date
Sep 21, 2026 For Q2 26
Estimate
-$1.82
Actual
-$2.09
Surprise
-14.47%
AYTU BioPharma, Inc. Common Stock
Report Date
Sep 22, 2026 For Q4 26
Estimate
-$0.33
Actual
-$0.05
Surprise
+84.92%
Neuphoria Therapeutics Inc. Common Stock
Report Date
Sep 18, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.95
Surprise
-66.32%
NewcelX Ltd. Ordinary Shares
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$0.54
Actual
-$0.96
Surprise
-77.58%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Amarin Corp Plc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Amarin Corp Plc reported EPS of $0.04, beating estimates by 492.16%, and revenue of $42.21M, -7.11% below expectations.
How did the market react to Amarin Corp Plc's Q2 2026 earnings?
The stock price moved up 1.51%, changed from $13.95 before the earnings release to $14.16 the day after.
When is Amarin Corp Plc expected to report next?
The next earning report is scheduled for Oct 27, 2026.
What are the forecasts for Amarin Corp Plc's next earnings report?
Based on 3
analysts, Amarin Corp Plc is expected to report EPS of -$0.02 and revenue of $44.58M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.